[1]
|
Quarles, L.D. (2003) Evidence for a Bone-Kidney Axis Regulating Phosphate Homeostasis. Journal of Clinical Investigation, 112, 642-646. http://dx.doi.org/10.1172/JCI200319687
|
[2]
|
Rowe, O.S. (2000) The molecular background to hypophosphatemic rickets. Archives of Disease in Childhood, 83, 192-194. http://dx.doi.org/10.1136/adc.83.3.192
|
[3]
|
Cho, H.Y., Lee, B.J., Kang, J.H., Ha, I.S., Cheong, H.I. and Choi, Y. (2005) A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatric Research, 58, 329-333. http://dx.doi.org/10.1203/01.PDR.0000169983.40758.7B
|
[4]
|
Bielesz, B., Klaushofer, K. and Oberbauer, R. (2004) Renal Phosphate Loss in Hereditary and Acquired Disorders of Bone Mineralization. Bone, 35, 1229-1239. http://dx.doi.org/10.1016/j.bone.2004.08.009
|
[5]
|
Rowe, P. (2004) The Wrickkened Pathways of FGF-23, MEPE and PHEX. Critical Reviews in Oral Biology & Medicine, 15, 264-281. http://dx.doi.org/10.1177/154411130401500503
|
[6]
|
de Beur, S.M.J. and Levine, M.A. (2002) Molecular Pathogenesis of Hypophosphatemic Rickets. The Journal of Clinical Endocrinology & Metabolism, 87, 2467-2473. http://dx.doi.org/10.1210/jcem.87.6.8688
|
[7]
|
Saggese, G. and Baroncelli, G.I. (2000) Hypophosphatemic Rickets. Hormone Research in Paediatrics, 53, 57-60. http://dx.doi.org/10.1159/000023535
|
[8]
|
Chaussain-Miller, C., Sinding, C., Septier, D., Wolikow, M., Goldberg, M., et al. (2007) Dentin Structure in Familial Hypophosphatemic Rickets: Benefits of Vitamin D and Phosphate Treatment. Oral Diseases, 13, 482-489. http://dx.doi.org/10.1111/j.1601-0825.2006.01326.x
|
[9]
|
Wharton, B. and Bishop, N. (2003) Rickets. Lancet, 362, 1389-1400. http://dx.doi.org/10.1016/S0140-6736(03)14636-3
|
[10]
|
Root, A.W. and Diamond Jr., F.B. (2002) Disorders of Calcium Metabolism in the Child and Adolescent. In: Sperling M.A., Ed., Pediatric Endocrinology, 2nd Edition, Saunders, Philadelphia, 646.
|
[11]
|
Garg, R.K. and Tandon, N. (1999) Hypophosphatemic Rickets: Easy to Diagnose, Difficult to Treat. Indian Journal of Pediatrics, 66, 849-857. http://dx.doi.org/10.1007/BF02723852
|
[12]
|
Winters, R., Grahan, J., Williams, T., McFalls, V. and Burnett, C. (1958) A Genetic Study of Familial Hypophosphatemia and Vitamin D Resistant Rickets with a Review of the Literature. Medicine, 37, 97-142. http://dx.doi.org/10.1097/00005792-195805000-00001
|
[13]
|
Segawa, H., Kaneko, I., Takahashi, A., Kuwahata, M., Ito, M., Ohkido, I., et al. (2002) Growth-Related Renal Type II Na/Pi Cotransporter. The Journal of Biological Chemistry, 277, 19665-19672. http://dx.doi.org/10.1074/jbc.M200943200
|
[14]
|
Murer, H., Forster, I. and Biber, J. (2004) The Sodium Phosphate Cotransporter Family SLC34. Pflugers Arch, 447, 763-767. http://dx.doi.org/10.1007/s00424-003-1072-5
|
[15]
|
Strewler, G.J. (2001) FGF23, Hypophosphatemia, and Rickets: Has Phosphatonin Been Found? Proceedings of the National Academy of Sciences of the United States of America, 98, 5945-5946. http://dx.doi.org/10.1073/pnas.111154898
|
[16]
|
Riminucci, M., Collins, M.T., Fedarko, N.S., Cherman, N., Corsi, A., White, K.E., et al. (2003) FGF-23 in Fibrous Dysplasia of Bone and Its Relationship to Renal Phosphate Wasting. The Journal of Clinical Investigation, 112, 683-692. http://dx.doi.org/10.1172/JCI18399
|
[17]
|
Bowe, A.E., Finnegan, R., de Beur, S.M.J., Cho, J., Levine, M.A., Kumar, R., et al. (2001) FGF-23 Inhibits Renal Tubular Phosphate Transport and Is a PHEX Substrate. Biochemical and Biophysical Research Communications, 284, 977-981. http://dx.doi.org/10.1006/bbrc.2001.5084
|
[18]
|
Dixon, P.H., Christie, P.T., Wooding, C., Trump, D., Grieff, M., Holm, I., et al. (1998) Mutational Analysis of PHEX Gene in X-Linked Hypophosphatemia. The Journal of Clinical Endocrinology & Metabolism, 83, 3615-3623.
|
[19]
|
Yamazaki, Y., Okazaki, R., Shibata, M., Hasegawa, Y., Satoh, K., Tajima, T., Takeuchi, Y., Fujita, T., Nakahara, K., Yamashita, T. and Fukumoto, S. (2002) Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/Osteomalacia. The Journal of Clinical Endocrinology & Metabolism, 87, 4957-4960. http://dx.doi.org/10.1210/jc.2002-021105
|
[20]
|
Rowe, P.S., Oudet, C.L., Francis, F., Sinding, C., Pannetier, S., Econs, M.J., Strom, T.M., Meitinger, T., Garabedian, M., David, A., Macher, M.A., Questiaux, E., Popowska, E., Pronicka, E., Read, A.P., Mokrzycki, A., Glorieux, F.H., Drezner, M.K., Hanauer, A., Lehrach, H., Goulding, J.N. and O’Riordan, J.L. (1997) Distribution of Mutations in the PEX Gene in Families with X-Linked Hypophosphataemic Rickets (HYP). Human Molecular Genetics, 6, 539-549. http://dx.doi.org/10.1093/hmg/6.4.539
|
[21]
|
Morey, M., Castro-Feijoo, L., Barreiro, J., Cabanas, P., Pombo, M., Gil, M., et al. (2011) Genetic Diagnosis of X-Linked Dominant Hypophosphstemic Rickets in a Cohort Study: Tubular Reabsorption of Phosphate and 1,25 (OH) 2D Serum Levels Are Asociated with PHEX Mutation Type. BMC Medical Genetics, 12, 116. http://dx.doi.org/10.1186/1471-2350-12-116
|
[22]
|
Alon, U.S., Levy-Olomucki, R., Moore, W.V., Stubbs, J., Liu, S. and Quarles, L.D. (2008) Calcimimetics as an Adjuvant Treatment for Familial Hypophosphatemic Rickets. Clinical Journal of the American Society of Nephrology, 3, 658-664. http://dx.doi.org/10.2215/CJN.04981107
|
[23]
|
Yavropoulou, M.P., Kotsa, K., Gotzamani Psarrakou, A., Papazisi, A., Tranga, T., Ventis, S. and Yovos, J.G. (2010) Cinacalcet in Hyperparathyroidism Secondary to X-Linked Hypophosphatemic Rickets: Case Report and Brief Literature Review. Hormones (Athens), 9, 274-278. http://dx.doi.org/10.14310/horm.2002.1277
|
[24]
|
Raeder, H., Shaw, N., Netelenbos, C. and Bjerknes, R. (2008) A Case of X-Linked Hypophosphatemic Rickets: Complications and the Therapeutic Use of Cinacalcet. European Journal of Endocrinology, S101-S105. http://dx.doi.org/10.1530/EJE-08-0383
|
[25]
|
Mäkitie, O., Doria, A., Kooh, S.W., Cole, W.G., Daneman, A. and Sochett, E. (2003) Early Treatment Improves Growth and Biochemical and Radiographic Outcome in X-Linked Hypophosphatemic Rickets. The Journal of Clinical Endocrinology & Metabolism, 88, 3591-3597. http://dx.doi.org/10.1210/jc.2003-030036
|
[26]
|
Pereira, C.M., Andrade, C.R., Vargas, P.A., Coletta, R.D., Almeida, O.P. and Lopes, M.A. (2004) Dental Alterations Associated with X-Linked Hypophosphatemic Rickets. Journal of Endodontics, 30, 241-245. http://dx.doi.org/10.1097/00004770-200404000-00015
|
[27]
|
Chaussain-Miller, C., Sinding, C., Wolikow, M., Lasfargues, J.J., Godeau, G. and Garabédian, M. (2003) Dental Abnormalities in Patients with Familial Hypophosphatemic Vitamin D-Resistant Rickets: Prevention by Early Treatment with 1-Hydroxyvitamin D. The Journal of Pediatrics, 142, 324-331.http://dx.doi.org/10.1067/mpd.2003.119
|
[28]
|
Haramati, A., Mulroney, S.E. and Lumpkin, M.D. (1990) Regulation of Renal Phosphate Reabsorption during Development: Implications from a New Model of Growth Hormone Deficiency. Pediatric Nephrology, 4, 387-391. http://dx.doi.org/10.1007/BF00862524
|
[29]
|
Brixen, K., Nielsen, H.K., Mosekilde, L. and Flyvbjerg, A. (1990) A Short Course of Recombinant Human Growth Hormone Treatment Stimulates Osteoblasts and Activates Bone Remodeling in Normal Human Volunteers. Journal of Bone and Mineral Research, 5, 609-618. http://dx.doi.org/10.1002/jbmr.5650050610
|
[30]
|
Brixen, K., Nielsen, H.K., Bouillon, R., Flyvbjerg, A. and Mosekilde, L. (1992) Effects of Short-Term Growth Hormone Treatment on PTH, Calcitriol, Thyroid Hormones, Insulin and Glucagon. Acta Endocrinology, 127, 331-336.
|
[31]
|
Baroncelli, G.I., Bertelloni, S., Ceccarelli, C. and Saggese, G. (2001) Effect of Growth Hormone Treatment on Final Height, Phosphate Metabolism, and Bone Mineral Density in Children with X-Linked Hypophosphatemic Rickets. Journal of Pediatrics, 138, 236-243. http://dx.doi.org/10.1067/mpd.2001.108955
|
[32]
|
Seikaly, M.G. and Baum, M. (1995) Stimulation of Growth Hormone Secretion in Children with x-Linked Hypophosphatemia. Pediatric Nephrology, 9, 751-752. http://dx.doi.org/10.1007/BF00868733
|
[33]
|
Seikaly, M.G., Brown, R. and Baum, M. (1997) The Effect of Recombinant Human Growth Hormone in Children with X-Linked Hypophosphatemia. Pediatrics, 100, 879-884. http://dx.doi.org/10.1542/peds.100.5.879
|
[34]
|
Makitie, O., Toiviainen-Salo, S., Marttinen, E., Kaitila, I., Sochett, E. and Sipila, I. (2008) Metabolic Control and Growth during Exclusive Growth Hormone Treatment in X-Linked Hypophosphatemic Rickets. Hormone Research in Paediatrics, 69, 212-220. http://dx.doi.org/10.1159/000113021
|